-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Diabetes is associated with an increased risk of heart failure (HF) and mortality, even after accounting for known cardiovascular risk factors .
Whether cardiac structural and functional abnormalities associated with dysglycemia are sufficient to explain the elevated risk of death or heart failure (HF) remains unclear .
In a recent study published in JAHA, an authoritative journal in the field of cardiovascular disease, researchers analyzed 6,059 participants ( Mean age was 75±5 years; 58% were female; 22% were black)
.
Participants were divided into three categories: no diabetes, prediabetes, and diabetes (as determined by medical history and glycated hemoglobin values)
.
We assessed whether diabetes altered the association between echocardiographic measures of cardiac structure and function and the composite outcome of all-cause death or hospitalization for heart failure .
We then estimated the degree of increased risk for the composite outcome associated with diabetes, primarily Explained by cardiac structure and function
heart failure
33.
5% of the subjects had diabetes
CONCLUSIONS: In a biracial cohort of older adults, cardiac structural and functional abnormalities partly explain the increased risk of diabetes-related events
.
.
Original source:
Original source:Riccardo M.